Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zai Lab (ZLAB) Long-Term Investments (2018 - 2024)

Zai Lab (ZLAB) has disclosed Long-Term Investments for 7 consecutive years, with $3.1 million as the latest value for Q4 2024.

  • Quarterly Long-Term Investments fell 66.21% to $3.1 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $3.1 million through Dec 2024, down 66.21% year-over-year, with the annual reading at $3.1 million for FY2024, 66.21% down from the prior year.
  • Long-Term Investments hit $3.1 million in Q4 2024 for Zai Lab, down from $3.2 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $20.8 million in Q3 2021 to a low of $1.1 million in Q2 2021.
  • Historically, Long-Term Investments has averaged $6.6 million across 5 years, with a median of $4.5 million in 2023.
  • Biggest five-year swings in Long-Term Investments: surged 1120.09% in 2021 and later tumbled 84.06% in 2022.
  • Year by year, Long-Term Investments stood at $1.3 million in 2020, then soared by 1120.09% to $15.6 million in 2021, then plummeted by 58.79% to $6.4 million in 2022, then skyrocketed by 43.37% to $9.2 million in 2023, then plummeted by 66.21% to $3.1 million in 2024.
  • Business Quant data shows Long-Term Investments for ZLAB at $3.1 million in Q4 2024, $3.2 million in Q3 2024, and $4.1 million in Q2 2024.